Most recently, CORXEL Pharmaceuticals raised $287.0M in its Later Stage VC (Series D1) (Jan 2026).
- ·The complete investor list: 13 names
- ·Watch CORXEL Pharmaceuticals: the Monday email on marks, rounds and moves
CORXEL Pharmaceuticals round by round
1 roundsHow much has CORXEL Pharmaceuticals raised?
CORXEL Pharmaceuticals has raised $452 million in total; 1 of its rounds is on record. The largest on record was a $287 million Series D1 in Jan 2026.
CORXEL Pharmaceuticals investors
13 investors are on record for CORXEL Pharmaceuticals, including RA Capital Management, New Enterprise Associates, The Invus Group and SR One Capital Management. By type, the record holds 3 hedge funds, 1 venture capital firm and 1 asset manager. The Series D1 in Jan 2026 drew 9 investors.
13 investors have backed CORXEL Pharmaceuticals — start your target list with the firms already writing checks in drug discovery.
Frequently asked about CORXEL Pharmaceuticals
- How much has CORXEL Pharmaceuticals raised?
- CORXEL Pharmaceuticals has raised $451.8M in total across 1 recorded funding rounds.
- When was CORXEL Pharmaceuticals's last funding round?
- CORXEL Pharmaceuticals's most recent recorded round was Later Stage VC (Series D1) in Jan 2026, raising $287.0M.